发明名称 |
MEDICAL INTERVENTION IN HAEMATOLOGICAL CANCERS |
摘要 |
The present invention relates to the medical and pharmaceutical use of substituted 1H-imidazo[4,5-c]quinolin-4-amines, in particular Imiquimod® and Gardiquimod®, alone or preferably in combination with Akt inhibitors, in particular with Akti1/2 and AktX, and most preferably with Akti1/2, in the treatment, prevention and/or amelioration of haematological cancers, in particular multiple myeloma disorders or B-cell disorders, and most particular in the therapy of multiple myeloma. |
申请公布号 |
EP2303273(A1) |
申请公布日期 |
2011.04.06 |
申请号 |
EP20090753664 |
申请日期 |
2009.05.26 |
申请人 |
MEDIZINISCHE UNIVERSITAET INNSBRUCK |
发明人 |
HUBER, LUKAS;SCHNAITER, SIMON;TINHOFER, INGE;JOEHRER, KARIN;GREIL, RICHARD |
分类号 |
A61K31/4745;A61K31/519;A61K31/538;A61K31/685;A61K31/7076;A61P35/02 |
主分类号 |
A61K31/4745 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|